Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A

• Egile Nagusiak: Liu L (Egilea), Lu J (Egilea), Allan BW (Egilea), Tang Y (Egilea), Tetreault J (Egilea), Chow C (Egilea), Barmettler B (Egilea), Nelson J (Egilea), Bina H (Egilea), Huang L (Egilea), Wroblewski VJ (Egilea), Kikly K (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2016-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Ling Liu,1 Jirong Lu,1 Barrett W Allan,2 Ying Tang,2 Jonathan Tetreault,1 Chi-kin Chow,1 Barbra Barmettler,2 James Nelson,2 Holly Bina,1 Lihua Huang,3 Victor J Wroblewski,4 Kristine Kikly1 1Biotechnology Discovery Research, Indianapolis, IN, 2Applied Molecular Evolution, Lilly Biotechnology...